Jesper Ericsson

VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas.

Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA.

Synthonics, Inc. operates as a pharmaceutical company. The firm discovers, develops and licenses drugs that incorporates with proprietary metal coordination chemistry. The company was founded by Thomas Piccariello in August 1993 and is headquartered in Blacksburg, VA.

Proxeon Biosystems ApS develops and sells technology, equipment, and supplies for biotechnology and clinical research. The company was founded by Ole Vorm on October 31, 2002 and is headquartered in Roskilde, Denmark.

Part of Recipharm AB, Recipharm Monts SAS is a company that manufactures sterile injectable anesthetic products. The company is based in Monts, France. Carl Ericson has been the CEO of the French company since 2019.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.

Diamorph AB engages in the research, development, and commercialization of glass and ceramic materials. It offers aerospace components, bearings, fire protection products, high temperature materials, rollers, rotary vanes, and wear resistant components. The company was founded by Ashkan Pouya and Saeid Esmaeilzadeh in 2003 and is headquartered in Stockholm, Sweden.

Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom.

SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden.

Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom.

Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom.

Part of Recipharm AB, Recipharm Strängnäs AB is a contract development and manufacturing organization in the pharmaceutical industry. The company is based in Strängnäs, Sweden. Founded in 2004, Recipharm Strängnäs operates as a contract development and manufacturing organization in the pharmaceutical industry.

Part of Viatris, Inc., Recip AB is a company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million.

Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden.

Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden.

Part of Recipharm AB, Aesica Holdco Ltd. operates as a holding British company. The company is based in Hemel Hempstead, UK.

Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden.

Part of Recipharm AB, Recipharm Fontaine SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Fontaine-les-Dijon, France. The company was founded in 2008. Pascal Prudent has been the CEO of the company since 2017.

Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest.

Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden.

Bohus BioTech AB is a Swedish company that manufactures and develops hyaluronic acid products. The company is based in Stromstad, Sweden and has subsidiaries in Sweden. The company was founded in 1992 by Daniel C. Ogbonnaya.

Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.

Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden.

Flerie Participation AB is an investment holding Swedish company. The company is based in Stockholm, Sweden.

Part of Recipharm AB, RPH Pharmaceuticals AB is a Swedish company that manufactures pharmaceutical products. The company is based in Jordbro, Sweden.

Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom.

Inject Pharma Sweden AB manufactures pharmaceutical products. The private company is based in Stockholm, Sweden.

Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The company is based in Uppsala, Sweden.

Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands.

Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber.

Part of Recipharm AB, Recipharm Verwaltungs GmbH is an investment holding German company. The company is based in Wasserburg am Inn, Germany. The CEOs of the company are Michael Isele, Thomas Bengt Eldered.

Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018.

Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom.

EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021.

Part of Recipharm AB, Consort Medical GmbH is a German company that functions as an investment holding company. The company is based in Monheim, Germany. The CEO of the company is Thomas Bengt Eldered.

Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château.

NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023.